Ibnsina Pharma S.A.E. (ISPH.CA)

Also known as:  ISP, Ibnsina
Data delayed by 15 minutes
9.71 EGP -0.51-4.99%
As of 22 SEP 2019 12:29 GMT|Egypt SE

ISP Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
0.547%
P/E (Last 12 Month)
28.611
Upside
-
Target Price (Mean)
-
52Wk
8.875 09 JAN
11.975 07 MAR

Open
10.10 EGP
Previous Close
10.22 EGP
Turnover
12.88M EGP
EPS
0.357 EGP
Volume
1,327,254
Transactions
160
Market Cap
8.38B EGP
IPO Date
08-Nov-2017
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

Lavasta Pharma launches family welfare product into the UAE

For the first time in the Middle East, a pharmaceutical product which is exclusively for women's personal life enhancement, has had its license approved and is now being distributed to pharmacies and hospitals across the region

Press Release - Sunday 22 September 2019
All Health Care News

Brexit hope on Juncker's word

Markets are at risk however of reading too much into Juncker's comment, and it remains to be seen whether the Pound can push on from current levels.

Opinion - 8 hours ago
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Omar Mohammed Abdel-Gawad Mahmoud
Co-Chief Executive Officer
Mr Mahmoud Mohammed Abdel-Gawad Mahmoud
Co-Chief Executive Officer
Mr Momen Gomaa
Chief Financial Officer

Board Members

Mr Mohammed Mohsen Mohammed Mahgoub
Chairman
Mr Abdulrahim Fahmi Omar
Director representing Faisal Islamic Bank of Egypt
Mr Lindsay Movar Forbes
Director representing European Bank for Reconstruction and Development
All People

About Ibnsina Pharma S.A.E.Last updated on: 17 October 2018

Business Summary
Distribution of pharmaceuticals, veterinary products, cosmetics, food supplements, pesticides, medical supplies and equipment.
Country of Incorporation
Ownership Type
Established In
2002
Primary Sector
Number of Employees
5667
Stock Listing
IDStock TypeCurrencyExchangeSymbol
ISPH.CASEOrdinaryEGPEgypt SEISPH

Contact details

Primary address
Ibnsina Pharma S.A.E. Building
Industrial Zone 1, Plot 2-3, Block 12-15
91
Egypt
Oubour
CONTACT
Related links
www.ebrd.com
Region
Qalyubia

Company information provided by © 2019 Thomson Reuters

Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.37.110 EGP-3.585
EGYPT INTL PHRM63.500 EGP-5.21
ALX. PHARMACEUT.99.100 EGP-5.258
MINAPHARM PHARMA84.950 EGP0.00
ARAB PHARMA30.510 EGP-4.983
GLAXO EGYPT19.760 EGP0.00
All Peers
#Morning Briefing

Sunday outlook: Oil prices, Asian shares retreat

Sunday outlook: Oil prices, Asian shares retreat

Brent crude futures fell 12 cents to settle at $64.28 a barrel, while U.S. West Texas Intermediate (WTI) crude futures ended 4 cents lower at $58.09 a barrel.

Read More

Most Viewed Stocks

Stock Market Data

Powered By Knowledge Direct

Stock Screener

All Stocks